Researchers recently reported the second update on the investigation of human genetic architecture with regards to the impact of coronavirus illness in a study that was published on the medRxiv* preprint service (COVID-19).
There have been 651.9 million confirmed cases of COVID-19 worldwide, along with 6.6 million fatalities. In order to reduce the morbidity brought on by COVID-19, studies have looked at several facets of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its effects on the human body. In order to identify the underlying processes that might influence unfavourable disease outcomes and accelerate the development of innovative drugs, it is imperative to comprehend the role of host genetic variables associated in COVID-19 susceptibility and severity.
About the study
Researchers updated their genome-wide association study (GWAS) on the susceptibility and severity of SARS-CoV-2 infections using data from the COVID-19 Host Genetic Initiative in the current study (HGI).
Three phenotypes were examined in more than 82 research from 35 different nations, including 36 studies with non-European heritage, as part of a meta-analysis conducted by the team. Critical illness, hospitalizations, and SARS-CoV-2 infection were the three phenotypes. Before SARS-CoV-2 vaccinations were widely available, the majority of these investigations were conducted. The researchers examined the statistical significance and effect magnitude between earlier and more recent analyses.
For identifying loci according to their propensity to play a role in either illness severity or susceptibility, two-class Bayesian models were used. In addition, the researchers assessed phenome-wide associations and linked the probable causative genes onto biological pathways.
Results
According to the study's findings, critical illness, hospitalisation, and SARS-CoV-2 infection are each associated with 21, 40, and 30 loci, respectively. With the addition of 28 notable loci to the 23 previously known loci from the COVID-19 HGI, there were almost 51 relevant loci across the genome that were observed for the three phenotypes. After adjusting for the number of phenotypes evaluated, 46 loci were still significant.
Nine loci may increase susceptibility to COVID-19, whereas six loci could not be classified, according to the Bayesian model, which found that 366 loci were considerably more likely to influence illness severity and hospitalization. The scientists observed that whereas the previously identified heterogenous locus FOXP4 demonstrated a comparable significance level to that previously reported, the 1q22 locus had notable variability in effect size across ancestries.
Phenome-wide association analysis revealed that 15 of the 51 loci could be linked to three critical pathways that affect COVID-19 severity and susceptibility, including viral entry, protection against viral entry in airway mucus, and type 1 interferon (IFN) response. These three pathways are viral entry, protection against viral entry in airway mucus, and type 1 IFN response. Nine loci were also found in the investigation to be related to maintaining healthy lung tissue. The viral entry pathway's putative causative genes included angiotensin-converting enzyme-2 (ACE-2), ABO, and transmembrane serine proteinase 2 in five of these loci (TMPRSS2). As a result of the interaction between anti-B and anti-A antibodies and the SARS-CoV-2 spike protein, which blocks viral entry, this supported the hypothesis that COVID-19 susceptibility and ABO blood types are related. Four of the nine loci that were discovered included potential causative genes linked to
The scientists also discovered that the 1q22 locus included an intergenic lead variation that boosted MUC1 expression in the mucosa of the stomach and decreased the risk of SARS-CoV-2 infection. Additionally, the 1q22 locus included a separate lead variation that decreased the incidence of COVID-19-related hospitalizations but not SARS-CoV-2 infection, pointing to several possible locus processes. Six loci included putative causative genes linked to the type 1 interferon pathway as well. The likelihood of developing a serious disease linked to SARS-CoV-2 was raised by a lead variation of IFN—10 (IFNA10) in the IFN- gene cluster. The scientists also discovered a lead variant on the genes that supported communication downstream of the IFN- receptor (IFNAR) that reduced the risk of hospitalizations and serious illness.
Conclusion
The study's findings demonstrated that by identifying an additional 28 loci, the second update of the GWAS improved the knowledge of host genetics currently engaged in COVID-19 severity and susceptibility. This increased number of loci makes it easier to tie genes to the pathways that are involved in SARS-CoV-2 entrance, airway mucus protection, and immune system response. The scientists think that more research is necessary to determine how the COVID-19 influence on the human genetic architecture is connected to the severity and susceptibility loci that are mapped to various pathways.
No comments:
Post a Comment